SCHEMBL6645358

SCHEMBL6645358

CN(C)c1cc(Cl)ccc1C(=O)Nc1ccc(N(CCn2nccc2NC(c2ccccc2)(c2ccccc2)c2ccccc2)C(=O)OC(C)(C)C)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR27 Q9NS67 1/20 0.37
TRPV4 Q9HBA0 1/20 0.34
POLB P06746 2/20 0.34
RAB9A P51151 1/20 0.34
ITGB1 P05556 1/20 0.33
ITGA4 P13612 1/20 0.33
F2 P00734 1/20 0.32
NR3C1 P04150 1/20 0.32
MAPT P10636 5/20 0.32
ALDH1A1 P00352 2/20 0.32
HTT P42858 2/20 0.32
MAPK1 P28482 2/20 0.32
MCL1 Q07820 2/20 0.32
TDP1 Q9NUW8 1/20 0.32
GAA P10253 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
MEN1 O00255 1/20 0.32
CYP2C19 P33261 1/20 0.32
KMT2A Q03164 1/20 0.32
AKR1C3 P42330 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6644367 0.90 DGAT1 (0.35) GPR27TRPV4NR3C1EPHX2
SCHEMBL6647477 0.84 MEN1 (0.38) GPR27TRPV4RAB9ANR3C1MAPT
SCHEMBL6648929 0.83 TAS1R3 (0.42) GPR27POLBRAB9ANR3C1MAPT
SCHEMBL6645363 0.83 IRAK4 (0.34) TRPV4F2ALDH1A1MAPK1TDP1
SCHEMBL6644597 0.81 F2 (0.39) GPR27POLBRAB9AITGB1ITGA4
SCHEMBL6643611 0.81 IRAK4 (0.37) POLBRAB9AMAPTHTTTDP1
SCHEMBL6645551 0.80 KMT2A (0.38) GPR27POLBALDH1A1MEN1KMT2A
SCHEMBL6644716 0.79 F2 (0.36) F2
SCHEMBL6644600 0.78 SCD (0.42) GPR27TRPV4POLBRAB9AMAPT
SCHEMBL6645976 0.76 TRPV4 (0.32) TRPV4POLBITGB1ITGA4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040133008-A1 Amide compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-07-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040133008-A1 Amide compounds APOB, APOL1, LDLR GPR27 1076/4885TRPV4 3973/4885POLB 1209/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.